Clinical trial
Phosphatidylethanol-Based Contingency Management to Reduce Alcohol Use and Improve Housing Outcomes
NCT04038021 is registered in ClinicalTrials.gov with Washington State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phosphatidylethanol-Based Contingency Management to Reduce Alcohol Use and Improve Housing Outcomes
- Lead sponsor
- Washington State University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 13, 2020
- Completion date
- October 27, 2022
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder